Atlas Trials

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Exocrine Pancreatic Dysfunction in Type 1 Diabetes

Clinical trial NCT05385211 · COMPLETED

Trial details

NCT number
NCT05385211
Sponsor
Ciusss de L'Est de l'Île de Montréal
Status
COMPLETED
Study type
OBSERVATIONAL
Type 1 DiabetesExocrine Pancreatic Insufficiency
Start date
2022-04-30
Primary completion
2023-08-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.